Results 41 to 50 of about 3,379 (229)
Treatment of vertigo in elderly patients with chronic cerebrovascular disease
Неврология, нейропсихиатрия, психосоматика, 2018 Dizziness can be caused by different problems in elderly patients; the possibilities of drug therapy are limited; betahistine dihydrochloride is most commonly used.Objective: to investigate the efficiency and safety of combination therapy with mexidol ...
S. N. Duma
doaj +1 more source
Brain Stimulation, 2023 BACKGROUND Meniere Disease is a clinical condition defined by hearing loss, tinnitus, and aural fullness symptoms, there are currently no any medications approved for its treatment.
Dong Wu +10 more
semanticscholar +1 more source
Histaminergic H3-Heteroreceptors as a Potential Mediator of Betahistine-Induced Increase in Cochlear Blood Flow [PDF]
, 2015 OBJECTIVE Betahistine is a histamine-like drug that is considered beneficial in Ménière's disease by increasing cochlear blood flow. Acting as an agonist at the histamine H1-receptor and as an inverse agonist at the H3-receptor, these receptors as well ...
Canis, Martin +5 more
core +1 more source
Medicine, 2023 Background: To evaluate the efficacy of Epley’s maneuver plus betahistine in the management of patients with posterior canal benign paroxysmal positional vertigo (PC-BPPV).
Wei Li +6 more
semanticscholar +1 more source
European Psychiatry, 2023 Introduction Despite being effective in schizophrenia, second-generation antipsychotics are potent histamine-H1 receptor antagonists associated with weight gain. Histaminergic agonists can potentially counteract the weight gain effects of antipsychotics.
Y. Soliman +7 more
doaj +1 more source
International Journal of Molecular Sciences, 2023 As a partial histamine H1 receptor agonist and H3 antagonist, betahistine has been reported to partially prevent olanzapine-induced dyslipidemia and obesity through a combination therapy, although the underlying epigenetic mechanisms are still not known.
Yue-Qing Su +3 more
semanticscholar +1 more source
Zagazig Journal of Pharmaceutical Sciences, 2019 A simple, precise and cost effective conductometric method was developed for determination of betahistine dihydrochloride and heptaminol hydrochloride in pure form and pharmaceutical formulations. The method is based on the precipitation of chloride ions
Magda M Ayad +3 more
doaj +1 more source
Betahistine for Ménière's disease or syndrome [PDF]
Cochrane Database of Systematic Reviews, 2001 Menière's disease is characterised by attacks of hearing loss, tinnitus and disabling vertigo. Betahistine is used by many people to reduce the frequency and severity of these attacks but there is conflicting evidence relating to its effects.The objective of this review was to assess the effects of betahistine in people with Menière's disease.We ...
A L, James, M J, Burton
openaire +2 more sources
Acta Otorrinolaringológica EspañolaVertigo is a frequent reason for medical consultation and may result from a wide range of aetiologies. Betahistine and the fixed low-dose combination of cinnarizine 20 mg and dimenhydrinate 40 mg are commonly used therapeutic options, each with distinct ...
D. Martín-Enguix +2 more
semanticscholar +1 more source
Journal of Anaesthesiology Clinical Pharmacology, 2013 Purpose: Patients undergoing middle ear surgery experience variable degrees of postoperative nausea and vomiting (PONV) despite prophylaxis and treatment with ondansetron or other 5HT 3 receptor antagonists.
Sandip Mukhopadhyay +5 more
doaj +1 more source